PBYI
Puma Biotechnology, Inc.
9.80$
+5.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +28.6% | -39.4% | +7.6% | +71.1% | -26.7% | -22.1% | +14.0% | +3.9% | +38.5% | -40.6% | +26.1% | – | |
| – | +83.1% | -55.9% | -0.7% | +173.0% | -52.2% | -24.2% | +16.5% | -1.0% | +90.0% | -54.9% | +19.7% | – | |
| – | +11.7% | -31.0% | +10.3% | +41.2% | -12.2% | -21.5% | +13.2% | +5.4% | +23.7% | -34.3% | +28.0% | – | |
| – | +12.5% | +5.5% | +0.3% | -8.0% | +20.9% | -8.6% | +11.5% | +3.0% | +5.8% | +17.5% | -4.5% | – | |
| – | -10.6% | +9.2% | +16.2% | -32.9% | +0.9% | +2.2% | +5.9% | -7.5% | +7.9% | +0.2% | -4.8% | – | |
| – | -3.5% | +6.9% | +9.2% | -23.9% | +8.3% | -1.0% | +6.5% | -2.3% | +7.6% | +8.5% | -4.6% | – | |
| – | +72.4% | -115.5% | – | – | -39.5% | -70.2% | +66.6% | +44.3% | +78.7% | -122.4% | – | – | |
| – | +0.4% | +0.1% | +0.4% | -8.1% | -15.5% | -16.9% | -15.6% | -18.9% | -24.8% | -34.7% | -75.4% | – | |
| – | +113.1% | -135.9% | – | – | -40.6% | -73.3% | +88.7% | +49.9% | +85.1% | -120.0% | – | – | |
| – | +151.6% | -59.0% | +71.8% | -23.0% | -2,528.5% | – | +5.8% | +28.7% | +819.5% | -91.1% | -82.8% | – | |
| – | +111.7% | -139.2% | – | – | -5.0% | -84.6% | +96.9% | +51.1% | +51.9% | -127.9% | – | – | |
| – | +49.8% | -90.9% | +28.2% | +1,148.8% | -33.4% | -53.4% | +30.6% | +25.0% | +55.2% | -100.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.